Markston International’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,665
Closed -$649K 160
2020
Q1
$649K Sell
3,665
-76,328
-95% -$14.4M 0.09% 82
2019
Q4
$15.3M Sell
79,993
-8,360
-9% -$1.51M 1.59% 21
2019
Q3
$14.9M Buy
88,353
+4,084
+5% +$665K 1.67% 20
2019
Q2
$14.1M Buy
84,269
+311
+0.4% +$43.1K 1.64% 20
2019
Q1
$12.3M Buy
83,958
+1,659
+2% +$241K 1.44% 26
2018
Q4
$11M Buy
82,299
+7,940
+11% +$1.3M 1.41% 25
2018
Q3
$14.2M Sell
74,359
-4,158
-5% -$764K 1.52% 21
2018
Q2
$14.5M Sell
78,517
-1,222
-2% -$196K 1.55% 18
2018
Q1
$13.4M Buy
79,739
+20,960
+36% +$3.52M 1.45% 22
2017
Q4
$9.62M Buy
58,779
+4,505
+8% +$808K 0.99% 35
2017
Q3
$11.1M Buy
54,274
+5,354
+11% +$1.25M 1.14% 31
2017
Q2
$11.9M Sell
48,920
-207
-0.4% -$48.6K 1.16% 30
2017
Q1
$11.7M Sell
49,127
-50
-0.1% -$11.6K 1.15% 31
2016
Q4
$10.3M Buy
49,177
+13,982
+40% +$2.9M 0.98% 41
2016
Q3
$8.11M Buy
35,195
+7,720
+28% +$1.89M 0.76% 51
2016
Q2
$6.35M Buy
+27,475
New +$6.33M 0.6% 67

Other funds holding AGN

Markston International's AGN Position: Q2 2020 in Review

Markston International sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,665 shares — an estimated $649K sold.

Markston International first reported a position in AGN in Q2 2016 and held it in 16 quarters. The position peaked at $15.3M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Markston International reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Markston International sold 3,665 Allergan plc shares in Q2 2020, an estimated $649K.
  • Markston International first reported a position in Allergan plc in Q2 2016 and held it in 16 quarters.
  • Markston International's Allergan plc position peaked at $15.3M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Markston International's 13F filing for Q2 2020, filed 18 Sep 2020.